Stay updated on Tulisokibart Efficacy Safety Ulcerative Colitis Clinical Trial
Sign up to get notified when there's something new on the Tulisokibart Efficacy Safety Ulcerative Colitis Clinical Trial page.

Latest updates to the Tulisokibart Efficacy Safety Ulcerative Colitis Clinical Trial page
- Check5 days agoChange DetectedThe page has been updated to reflect an increase in study locations from 423 to 430, with several new recruiting sites added in various countries, including the United States, Canada, and Georgia. Additionally, some outdated contact information and locations have been removed.SummaryDifference2%
- Check13 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check20 days agoChange DetectedThe page now indicates that the study has increased from 422 to 423 locations and has updated contact information for the Study Coordinator in Englewood, Colorado. Additionally, the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input.SummaryDifference0.6%
- Check27 days agoChange DetectedThe webpage has updated its study locations, increasing the total from 413 to 422, and has added several new recruiting sites across various countries, including Spain, Slovakia, and the United States. Additionally, some registry identifiers have been removed.SummaryDifference6%
- Check57 days agoChange DetectedThe webpage has been updated to reflect a new clinical trial protocol for evaluating the efficacy of tulisokibart in participants with moderately to severely active ulcerative colitis, including new study details, locations, and contact information. The trial now includes a broader range of recruiting sites across various countries.SummaryDifference45%
- Check228 days agoChange DetectedNew recruitment sites have been added across various countries including Bulgaria, China, Colombia, France, Italy, Japan, Poland, Slovakia, Spain, Turkey, and the UK, while one site in Israel has been removed.SummaryDifference6%
Stay in the know with updates to Tulisokibart Efficacy Safety Ulcerative Colitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tulisokibart Efficacy Safety Ulcerative Colitis Clinical Trial page.